Achilles Therapeutics plc (ACHL)
Company Info
| ISIN | US00449L1026 |
|---|---|
| CUSIP | 00449L102 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $38.90M |
|---|---|
| EPS | -$1.89 |
| EBITDA (TTM) | -$64.23M |
| Year Range | $0.75 - $2.52 |
| Target Price | $8.80 |
| Short % | 3.59% |
| Short Ratio | 0.41 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Achilles Therapeutics plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Achilles Therapeutics plc had a return of 2.60% year-to-date (YTD) and -65.74% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | 3.75% | -3.58% |
| 6 months | 1.91% | 5.75% |
| Year-To-Date | 2.60% | 10.93% |
| 1 year | -65.74% | 16.78% |
| 5 years (annualized) | -68.77% | 2.96% |
| 10 years (annualized) | N/A | N/A |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -11.29% | -12.95% | -13.32% | 20.48% | -5.48% | 7.91% | -8.80% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Achilles Therapeutics plc (ACHL) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ACHL Achilles Therapeutics plc | -1.05 | ||||
^GSPC S&P 500 | 0.98 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Achilles Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Achilles Therapeutics plc is 95.58%, recorded on Dec 21, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.58% | Apr 7, 2021 | 432 | Dec 21, 2022 | — | — | — |
| -9.85% | Apr 1, 2021 | 2 | Apr 5, 2021 | 1 | Apr 6, 2021 | 3 |
Volatility Chart
The current Achilles Therapeutics plc volatility is 16.17%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.